ANI Pharmaceuticals

ANIP68

$54.07arrow_drop_down2.12%-$1.17

ANIP68

$54.07

arrow_drop_down2.12%-$1.17

Performance History

Key Stats
Open	$56.73
Prev. Close	$56.58
EPS	-0.47
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	55.13	58.42
52 Week Range	48.20	70.81

Ratios







EPS	-0.47

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc (ANIP) is a pharmaceutical company that specializes in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. With a focus on niche markets, ANI Pharmaceuticals aims to provide high-quality, cost-effective medications to patients and healthcare professionals. The company's product portfolio includes oral solid dose products, injectables, and specialized non-commercialized products. ANI Pharmaceuticals also offers contract manufacturing services to other pharmaceutical companies. As of the most recent data, ANI Pharmaceuticals has a market capitalization of $XXX billion.

With a diverse product portfolio and a strong pipeline of future products, ANI Pharmaceuticals is well-positioned for growth. The company's success can be attributed to its strategic focus on niche markets and its commitment to quality. By targeting underserved patient populations, ANI Pharmaceuticals has been able to establish a strong competitive advantage in the pharmaceutical industry. The company's generic products offer cost savings to patients, while its branded products provide innovative treatment options. ANI Pharmaceuticals also leverages its contract manufacturing capabilities to generate additional revenue streams. With a PEG ratio of X.XX, ANI Pharmaceuticals stock may be undervalued compared to its industry peers.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Nikhil Lalwani
Headquarters: Baudette
Employees: 600
Exchange: NASDAQ

Keep an eye on ANI Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is ANI Pharmaceuticals 's (ANIP) price per share?

The current price per share for ANI Pharmaceuticals (ANIP) is $54.08. The stock has seen a price change of -$1.17 recently, indicating a -2.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for ANI Pharmaceuticals (ANIP)?

For ANI Pharmaceuticals (ANIP), the 52-week high is $70.81, which is 30.95% from the current price. The 52-week low is $48.2, the current price is 12.19% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is ANI Pharmaceuticals (ANIP) a growth stock?

ANI Pharmaceuticals (ANIP) has shown an average price growth of -6.8% over the past three years. It has received a score of 65 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ANI Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is ANI Pharmaceuticals (ANIP) stock price performance year to date (YTD)?

As of the latest data, ANI Pharmaceuticals (ANIP) has a year-to-date price change of -5.45%. Over the past month, the stock has experienced a price change of -10.34%. Over the last three months, the change has been -11.69%. Over the past six months, the figure is -12.4%. Looking at a longer horizon, the five-year price change stands at -3.58%.

help

Is ANI Pharmaceuticals (ANIP) a profitable company?

ANI Pharmaceuticals (ANIP) has a net income of $18.78M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 62.71% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.34% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $486.82M, with a revenue growth rate of 53.87%, providing insight into the company's sales performance and growth. The gross profit is $305.3M. Operating income is noted at $46.97M. Furthermore, the EBITDA is $109.16M.

help

What is the market capitalization of ANI Pharmaceuticals (ANIP)?

ANI Pharmaceuticals (ANIP) has a market capitalization of $1.16B. The average daily trading volume is 54.01, indicating the stock's liquidity and investor engagement.